Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAZontag and Zontag used a retrospective cohort design to evaluate the risk of smell and taste disturbances in patients being treated with glucagon-like peptide-1 agonists (GLP-1 RA). They used health records from a large electronic health records database (TriNetX Global Collaborative Network) encompassing more than 120 health care organizations to query adults with type 2 diabetes (T2D) without preexisting smell or taste disturbances. The exposure cohort received a GLP-1 RA while the control cohort was prescribed T2D medications without a GLP-1 RA. Each cohort had more than 400 000 patients. The authors found that the GLP-1 RA cohort had an increased risk of overall taste and disturbances (hazard ratio, 1.48; 95% CI, 1.37-1.61). The authors suggest that GLP-1 RA therapy is associated with a higher risk of smell and taste disturbance and raise a call for public health awareness.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Smell and Taste Disturbances Among Glucagon-Like Peptide-1 Receptor Agonist Users | 0 | 7 | 25-06-2026 |
| 2 | Weight-loss jab users more likely to report changes in taste and smell, study finds | 0 | 7 | 29-06-2026 |
| 3 | Ученые сообщили о новых рисках приема "Оземпика" | -2 | 7 | 26-06-2026 |
| 4 | GLP-1 减肥药与脱发相关 | 0 | 6.55 | 24-07-2026 |
| 5 | Secondary Ocular Complications Associated with GLP-1 Receptor Agonist Use for Weight Loss: A Large Retrospective Cohort Study | 0 | 5 | 17-07-2026 |
| 6 | Los GLP-1, relacionados con mayor riesgo de caída del cabello | 0 | 8.31 | 27-07-2026 |
| 7 | GLP-1s may improve outcomes in patients with PAD, diabetes | 5 | 7 | 08-07-2026 |
| 8 | Прием семаглутида удваивает вероятность развития дистрофии сетчатки у диабетиков | 0 | 0 | 05-06-2025 |
| 9 | أوزمبيك.. هل يدفع الفم ثمن خسارة الوزن؟ | -2 | 6 | 23-06-2026 |
| 10 | Comparison of Diet and Lifestyle Program With 3 Medication Approaches for Laryngopharyngeal Reflux Disease | 0 | 7 | 02-07-2026 |